Genenta Science S.p.A. ADR Company Profile
NASDAQ: GNTAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.7261 +2.25%
Genenta Science S.p.A. at a glance
Genenta Science S.p.A. ADR (NASDAQ: GNTA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Milan, MI, Italy. Genenta Science S.p.A. is led by Mr. Pierluigi Paracchi and employs about 9 people. The company's shares have traded publicly since 2021.
At a market capitalization of $34.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001838716, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Genenta Science S.p.A. do?
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Business description based on the company's public filings.
Company information
- Legal name
- Genenta Science S.p.A. ADR
- Ticker
- NASDAQ: GNTA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Pierluigi Paracchi
- Employees
- 9
- Headquarters
- Via dell’Annunciata 31, Milan, MI, Italy
- Phone
- 39 02 29 00 10 55
- Website
- genenta.com
- IPO year
- 2021
- Market cap
- $34.24M
- SEC CIK
- 0001838716
Companies similar to Genenta Science S.p.A.
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CVMCel-Sci Corporation | 1.95 | -8.45% | $34.30M | vs GNTA |
| ALGSAligos Therapeutics Inc. | 5.31 | -0.19% | $33.16M | vs GNTA |
| ELUTElutia Inc. Class A | 0.8273 | +0.88% | $36.64M | vs GNTA |
| MGXMetagenomi Therapeutics Inc. | 0.9932 | +0.86% | $37.52M | vs GNTA |
| QNCXQuince Therapeutics Inc. | 29.36 | +9.88% | $29.86M | vs GNTA |
| EVAXEvaxion A/S ADR | 3.05 | -2.87% | $27.52M | vs GNTA |
| ATYRaTyr Pharma Inc. | 0.2553 | -8.26% | $25.04M | vs GNTA |
| TILInstil Bio Inc. | 6.56 | -4.23% | $44.49M | vs GNTA |